---
title: "OVLY: Q2 2026 net income fell on higher expenses, but loan growth and asset quality remained strong"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293650220.md"
description: "Q2 2026 net income declined year-over-year due to higher non-interest expense and lower non-interest income, despite loan growth and a steady net interest margin. Asset quality remained strong, and a $0.375 per share dividend was declared.Original document: Oak Valley Bancorp (CA) [OVLY] SEC 8-K Current Report — Jul. 23 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-07-23T17:16:28.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293650220.md)
  - [en](https://longbridge.com/en/news/293650220.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293650220.md)
generator: "portal-rs"
---

# OVLY: Q2 2026 net income fell on higher expenses, but loan growth and asset quality remained strong

Q2 2026 net income declined year-over-year due to higher non-interest expense and lower non-interest income, despite loan growth and a steady net interest margin. Asset quality remained strong, and a $0.375 per share dividend was declared.

Original document: Oak Valley Bancorp (CA) \[OVLY\] SEC 8-K Current Report — Jul. 23 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [OVLY.US](https://longbridge.com/en/quote/OVLY.US.md)

## Related News & Research

- [Oak Valley Bancorp director Daniel Leonard acquires 125 common shares valued at $4,323.75](https://longbridge.com/en/news/296544411.md)
- [Insider Move at Oak Valley Bancorp Signals Growing Confidence](https://longbridge.com/en/news/293997795.md)
- [3 Next-Gen AI Stocks That 3G Capital Bought in Q2](https://longbridge.com/en/news/296496173.md)
- [INVEST: Revenue and profit dropped sharply in H1 2026, with 2026 outlook remaining subdued](https://longbridge.com/en/news/296439091.md)
- [EGTX: Q2 2026 revenue up 23% YoY; U.S. Emcitate launch expected Q4 2026 pending FDA approval](https://longbridge.com/en/news/296636890.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**